首页> 外文期刊>Chemical engineering journal >Photodegradation mechanism and genetic toxicity of bezafibrate by Pd/g-C3N4 catalysts under simulated solar light irradiation: The role of active species
【24h】

Photodegradation mechanism and genetic toxicity of bezafibrate by Pd/g-C3N4 catalysts under simulated solar light irradiation: The role of active species

机译:PD / G-C3N4催化剂在模拟太阳光照射下PD / G-C3N4催化剂的光降解机理和遗传毒性:活性物种的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Fibrate pharmaceuticals are a group of ubiquitous emerging pollutants, which pose a potential threat to eco-system and human health. Photocatalysis with inexhaustible solar energy is a sustainable option for fibrate pharmaceuticals photolysis removal from water. For high-efficiency use of solar light, the designed low-cost and high-activity solar-driven Pd/g-C3N4 photocatalysts took full advantages of the Pd plasmonic and electrons transformation for photocatalysis. The Pd/g-C3N4 photocatalysts with different Pd deposition were systematically designed and applied to investigate the degradation of bezafibrate (BZF), a representative fibrate pharmaceutical with two benzene rings and a fibrate chain in its structure. The as-prepared Pd/g-C3N4 catalysts presented promising photocatalytic activities in BZF degradation with respect to that of g-C3N4 under simulated solar (2.9 times) and visible light irradiation (2.4 times), as well as photocatalytic stability. The possible active species produced during the photocatalytic process of BZF were unveiled and verified by quenching electron spin resonance (ESR) analysis. Results revealed that hydroxyl radical (center dot OH) contributed 79.39% of BZF degradation. Three main possible photocatalytic pathways of BZF were also proposed with the calculation of frontier election density (FED), including R-oxy substituent, center dot OH-addition and oxidative dechlorination. The utilization of Pd/g-C3N4 catalysts was considered to be low toxicity and safe, and the genotoxicity of BZF solution could be decreased after photodegradation. This study presents a feasible approach for the enhancement removal of fibrate pharmaceuticals with the energy utilization from natural sunlight.
机译:匹配药物是一组无处不在的新兴污染物,对生态系统和人类健康构成了潜在的威胁。光催化与无穷无尽的太阳能是匹配药物光解除去水的可持续选择。对于太阳能光的高效使用,设计的低成本和高活动太阳能驱动的PD / G-C3N4光催化剂采用了PD等离子体和电子转化为光催化的充分优势。系统地设计和应用具有不同PD沉积的PD / G-C3N4光催化剂,以研究Bezafbibrate(BZF)的降解,该代表性纤维类药物具有两个苯环和其结构的纤维链。制备的Pd / G-C3N4催化剂在模拟太阳(2.9次)下的G-C3N4的BZF降解中呈现了有前途的光催化活性,并且可见光照射(2.4次),以及光催化稳定性。通过淬火电子自旋共振(ESR)分析,推出在BZF的光催化过程中产生的活性物质。结果表明,羟基(中心点OH)占BZF降解的79.39%。还提出了三种主要可能的BZF光催化途径,并计算了前沿选配密度(FED),包括R-氧取代基,中心点OH-加法和氧化脱氯。 PD / G-C3N4催化剂的利用被认为是低毒性和安全性,并且在光降解后可以降低BZF溶液的遗传毒性。该研究提出了一种可行的方法,用于从自然阳光下的能量利用中提高匹配药物的去除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号